A nyelocsorák kockázati tényezoi és lehetséges genetikai háttere

Translated title of the contribution: Epidemiology and pathogenesis of esophageal cancer, and the possibilities of its prevention

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Esophageal cancer is the sixth most common cancer mortality, with increasing incidence. 95% of the esophageal cancer is squamous cell carcinoma or adenocarcinoma. Although they differ in histology and epidemiology, some of their risk factors (smoking, dietary factors) and their pathogenesis are the same. More than 90% of esophageal cancer is diagnosed in late stage. Despite the development of diagnostic and therapeutic techniques, esophageal cancer has poor prognosis, with 5-year survival rates between 10-13%. Understanding the exact pathogenesis can help the prevention of this highly aggressive cancer, with the use of natural substances and nonsteroid inflammatory drugs.

Original languageHungarian
Pages (from-to)407-413
Number of pages7
JournalOrvosi Hetilap
Volume150
Issue number9
DOIs
Publication statusPublished - Mar 1 2009

Fingerprint

Esophageal Neoplasms
Epidemiology
Squamous Cell Carcinoma
Neoplasms
Histology
Adenocarcinoma
Survival Rate
Smoking
Mortality
Incidence
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A nyelocsorák kockázati tényezoi és lehetséges genetikai háttere. / Hagymási, K.; Tulassay, Z.

In: Orvosi Hetilap, Vol. 150, No. 9, 01.03.2009, p. 407-413.

Research output: Contribution to journalArticle

@article{d8e97f4b74fe40ceb5c54a6189c637a0,
title = "A nyelocsor{\'a}k kock{\'a}zati t{\'e}nyezoi {\'e}s lehets{\'e}ges genetikai h{\'a}ttere",
abstract = "Esophageal cancer is the sixth most common cancer mortality, with increasing incidence. 95{\%} of the esophageal cancer is squamous cell carcinoma or adenocarcinoma. Although they differ in histology and epidemiology, some of their risk factors (smoking, dietary factors) and their pathogenesis are the same. More than 90{\%} of esophageal cancer is diagnosed in late stage. Despite the development of diagnostic and therapeutic techniques, esophageal cancer has poor prognosis, with 5-year survival rates between 10-13{\%}. Understanding the exact pathogenesis can help the prevention of this highly aggressive cancer, with the use of natural substances and nonsteroid inflammatory drugs.",
keywords = "Adenocarcinoma, Epidemiology, Esophageal cancer, Pathogenesis, Prevention, Protooncogenes, Risk factors, Squamous cell carcinoma, Tumorsuppressors",
author = "K. Hagym{\'a}si and Z. Tulassay",
year = "2009",
month = "3",
day = "1",
doi = "10.1556/OH.2009.28558",
language = "Hungarian",
volume = "150",
pages = "407--413",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "9",

}

TY - JOUR

T1 - A nyelocsorák kockázati tényezoi és lehetséges genetikai háttere

AU - Hagymási, K.

AU - Tulassay, Z.

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Esophageal cancer is the sixth most common cancer mortality, with increasing incidence. 95% of the esophageal cancer is squamous cell carcinoma or adenocarcinoma. Although they differ in histology and epidemiology, some of their risk factors (smoking, dietary factors) and their pathogenesis are the same. More than 90% of esophageal cancer is diagnosed in late stage. Despite the development of diagnostic and therapeutic techniques, esophageal cancer has poor prognosis, with 5-year survival rates between 10-13%. Understanding the exact pathogenesis can help the prevention of this highly aggressive cancer, with the use of natural substances and nonsteroid inflammatory drugs.

AB - Esophageal cancer is the sixth most common cancer mortality, with increasing incidence. 95% of the esophageal cancer is squamous cell carcinoma or adenocarcinoma. Although they differ in histology and epidemiology, some of their risk factors (smoking, dietary factors) and their pathogenesis are the same. More than 90% of esophageal cancer is diagnosed in late stage. Despite the development of diagnostic and therapeutic techniques, esophageal cancer has poor prognosis, with 5-year survival rates between 10-13%. Understanding the exact pathogenesis can help the prevention of this highly aggressive cancer, with the use of natural substances and nonsteroid inflammatory drugs.

KW - Adenocarcinoma

KW - Epidemiology

KW - Esophageal cancer

KW - Pathogenesis

KW - Prevention

KW - Protooncogenes

KW - Risk factors

KW - Squamous cell carcinoma

KW - Tumorsuppressors

UR - http://www.scopus.com/inward/record.url?scp=64049091919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64049091919&partnerID=8YFLogxK

U2 - 10.1556/OH.2009.28558

DO - 10.1556/OH.2009.28558

M3 - Article

C2 - 19228569

AN - SCOPUS:64049091919

VL - 150

SP - 407

EP - 413

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 9

ER -